Purification of Complex mAb Modalities

Facing challenges when purifying non-traditional mAbs?
Sept. 24, 2025

As monoclonal antibody (mAb) modalities become increasingly complex, traditional purification methods often fall short. This article provides invaluable insights from three in-house specialists at Thermo Fisher Scientific, addressing the unique challenges faced in the purification of complex mAbs.

Key Takeaways:

  • Learn how to optimize purification strategies for non-traditional mAbs with the help of affinity chromatography technology
  • Discover new approaches to tackle impurities introduced by novel mAb structures.
  • Learn how you can refine your polishing processes to achieve maximum efficiency.

Equip yourself with the knowledge to navigate the complexities of mAb purification and elevate your process development strategies.